14 subscribers
ออฟไลน์ด้วยแอป Player FM !
AUDIO JOURNAL OF ONCOLOGY—New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma
Manage episode 346737320 series 1256601
New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma
Interview with:
Maria Reig MD PhD, Professor and Head of the Barcelona Clinic Liver Cancer (BCLC) Unit, Hospital Clinic Barcelona at Barcelona University, Spain.
BARCELONA, Spain—A phase one study of new drug targeting the monopolar spindle 1 enzyme was found to be safe—with reversible neutropenia as the commonest side effect—and to have clinical activity in patients with relapsed or refractory unresectable hepatocellular carcinoma (HCC). Maria Reig MD PhD announced the study findings at the 2022 European Organisation for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research (EORTC-NCI-AACR) Symposium on Molecular Targets and Cancer Therapeutics.
She gave the Audio Journal of Oncology’s Peter Goodwin more details of this new type of treatment, that she says works in a very different way from the current options for treating liver cancer.
51 ตอน
Manage episode 346737320 series 1256601
New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma
Interview with:
Maria Reig MD PhD, Professor and Head of the Barcelona Clinic Liver Cancer (BCLC) Unit, Hospital Clinic Barcelona at Barcelona University, Spain.
BARCELONA, Spain—A phase one study of new drug targeting the monopolar spindle 1 enzyme was found to be safe—with reversible neutropenia as the commonest side effect—and to have clinical activity in patients with relapsed or refractory unresectable hepatocellular carcinoma (HCC). Maria Reig MD PhD announced the study findings at the 2022 European Organisation for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research (EORTC-NCI-AACR) Symposium on Molecular Targets and Cancer Therapeutics.
She gave the Audio Journal of Oncology’s Peter Goodwin more details of this new type of treatment, that she says works in a very different way from the current options for treating liver cancer.
51 ตอน
ทุกตอน
×
1 AUDIO JOURNAL OF ONCOLOGY: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS 13:47

1 AUDIO JOURNAL OF ONCOLOGY: Safe to Spare Post-Mastectomy Chest Wall Radiotherapy in Most Patients with Intermediate Risk Breast Cancer 15:27

1 AUDIO JOURNAL OF ONCOLOGY: Increased Dietary Fiber Brings Longer Survival and Less GVHD After Allogeneic Stem Cell Transplantation 12:28

1 Adding a Bi-Specific T-Cell Engager Brings Striking Benefit in Childhood Acute Lymphoblastic Leukemia 13:07

1 Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia 7:26

1 Low Rates of Early Detection Drive Excess Breast Cancer Mortality in Underserved Communities 24:31

1 AUDIO JOURNAL OF ONCOLOGY—Options Identified for Chemotherapy Intensity Reduction in Acute Lymphoblastic Leukemia 13:34

1 AUDIO JOURNAL OF ONCOLOGY—Don’t Delay Stem Cell Transplant For Patients with Relapsed or Refractory Acute Myeloid Leukemia 15:06

1 AUDIO JOURNAL OF ONCOLOGY—Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma 16:28

1 AUDIO JOURNAL OF ONCOLOGY—Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre-Treated Multiple Myeloma 20:54

1 AUDIO JOURNAL OF ONCOLOGY—High Response Rates in Lung Cancer from Next Generation ROS1 Inhibitor 12:07

1 AUDIO JOURNAL OF ONCOLOGY—ARROS-1 Study Finds ROS1 Tyrosine Kinase Inhibitor Has Promise as a Tumor Agnostic Therapy 13:59

1 AUDIO JOURNAL OF ONCOLOGY—Pan-AKT Inhibitor Tumor Agnostic Targeting was Safe and Effective in Phase One Study 10:16

1 AUDIO JOURNAL OF ONCOLOGY—New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma 17:40
ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ